In the present study, our results reveal a novel function for and mechanism of TPX2 enhancement of the metabolism and clearance of antitumor drugs by HCC cells and/or resistance of HCC cells to antitumor drugs via the role of TPX as a co-activator of PXR. This evidence concerns the gene NR1I2 and hepatocellular carcinoma.